Abstract Details Title Natalizumab and Risk of Melanoma: A Prospective Follow-Up of Patients Treated by Natalizumab for Multiple Sclerosis Topic MS and Related Diseases Presentation(s) (-) Poster/Presentation Number 115 Objective Background Design/Methods Results Conclusions Authors/Disclosures No disclosure on file No disclosure on file No disclosure on file